Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Cash from Operations (2016 - 2025)

Pediatrix Medical (MD) has disclosed Cash from Operations for 17 consecutive years, with 110956000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Operations fell 17.69% to 110956000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 271091000.0, a 24.78% increase, with the full-year FY2025 number at 271091000.0, up 24.78% from a year prior.
  • Cash from Operations was 110956000.0 for Q4 2025 at Pediatrix Medical, down from 140431000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 140431000.0 in Q3 2025 to a low of 122624000.0 in Q1 2024.
  • A 5-year average of 46086900.0 and a median of 80598500.0 in 2021 define the central range for Cash from Operations.
  • Biggest YoY gain for Cash from Operations was 229.81% in 2021; the steepest drop was 77.53% in 2021.
  • Pediatrix Medical's Cash from Operations stood at 81259000.0 in 2021, then surged by 40.36% to 114057000.0 in 2022, then crashed by 39.28% to 69250000.0 in 2023, then surged by 94.66% to 134805000.0 in 2024, then fell by 17.69% to 110956000.0 in 2025.
  • Per Business Quant, the three most recent readings for MD's Cash from Operations are 110956000.0 (Q4 2025), 140431000.0 (Q3 2025), and 137167000.0 (Q2 2025).